CD36 and gastric cancer: GC patients with deep tumor invasion (T3 and T4), high pStage (stages III and IV) and more positive lymph nodes (>5) had significantly higher expression of CD36 than those with superficial tumor invasion (T1 and T2), low TNM stage (stages I and II) and fewer positive lymph nodes (≤5) (Table 1).